The progression of neoplastic disease is characterized by specific alterations of energy metabolism and by symptoms like fatigue, anorexia, nausea, anaemia and immunodepression, which [7] . Therefore, in advanced cancer patients oxidative stress (OS) may be considered a manifestation of reduced food intake and impaired glucose utilization [4, 8, 9] .
IL-1 and tumour necrosis factor (TNF) ␣
, released by the tumour and the activated immune cells [14] . Proinflammatory cytokines, in turn, are able to induce an acute phase protein response that contributes to the pathogenesis of the altered energy metabolism [11] . Recently, the relationship between inflammatory status and changes of energy metabolism has been studied. Leptin, a protein considered the key marker of the nutritional status and energy consumption, is the central mediator connecting nutrition and immunity. It is released from adipocytes at concentrations proportional to body fat content [15, 16] and informs the central regulatory processes thus regulating body weight [17] . Although the fat amount is the main determinant of leptin concentrations, other factors are also relevant, including sex, hormones (i.e. insulin) and inflammation [18] . Several studies have evaluated the anorectic role of leptin and its correlation with body composition in cancer patients. However, to date the relationship between leptin, proinflammatory cytokines and their metabolic consequences during cancer progression has not been assessed yet. [7, 19] . 
The above reported observations led us in the present study to use leptin and oxidative stress variables (ROS, GPx and SOD) as parameters of energy metabolic status. Indeed, in a small sample of cachectic patients we observed a correlation between the changes of specific parameters of energy metabolism (i.e. body composition, resting energy expenditure, grip strength, etc.) and circulating levels of leptin, ROS and GPx

The aim of the present study was to assess the correlation between the circulating levels of parameters of inflammation (C-Reactive Protein, CRP, Fibrinogen, IL-6, TNF␣ and IL-1␤) and energy metabolic status (leptin, body mass index (BMI), ROS, GPx and SOD) in epithelial ovarian
Clinical and anthropometric measurements
Clinical evaluation included chest x-ray and abdomino-pelvic ultrasound, computed tomography (CT) and CA-125 assessment. To complete the surgical stadiation and establish the most appropriate surgical approach, laparoscopy abdominal exploration was performed for all patients [21, 22] 
Results
Assessment of parameters of inflammation and energy metabolic status in 95 healthy controls and 104 ovarian cancer patients at diagnosis
Levels of IL-6, IL-1␤, TNF-␣, CRP, fibrinogen and ROS were significantly higher, while leptin, GPx and SOD were significantly lower, in patients with stages III-IV epithelial ovarian cancer compared to controls and patients with stages I-II. Patients at stages I-II of disease, in turn, showed significantly lower ROS levels compared to controls (Table 2).
Linear univariate regression analysis between clinical parameters and parameters of inflammation and energy metabolic status
Single regression analysis showed that stage of disease and Eastern Cooperative Oncology Group (ECOG) PS were positively significantly correlated with IL-6, CRP, ROS and inversely correlated with leptin levels and BMI (Table 3).
Linear univariate regression analysis between parameters of inflammation and energy metabolic status
Linear regression analysis showed that serum IL-6 levels correlated with leptin, ROS and GPx, while CRP levels correlated with BMI and ROS levels ( [29] . Higher serum IL-6 levels have been found in ovarian cancer patients compared with other gynaecological malignancies [30] and have been correlated with tumour burden, clinical disease status, reduced responsiveness to chemotherapy and poor relapse-free and overall survival [30] [31] [32] . However, it is difficult to establish the source of IL-6 and whether its high production in patients with ovarian carcinoma may be attributable to tumour [33] or immune system cells [34] . [37, 38] and fatigue [39] . In patients with epithelial ovarian carcinoma high IL-6 levels were associated with an impaired efficiency of immune cells both in terms of PBMC reduced blastic response and membrane-bound IL-2 receptor expression [40] . In the same way IL-6 exerts a central role in the pathogenesis of cancer-related anaemia [26] . Additionally, the highest serum levels of IL-6 are associated with the poorest physical/functional well-being (depression, anxiety, reduced social interaction) and the greatest fatigue [41] [3, 4] and are in accordance with those of very important recent studies performed on a wide population of newly diagnosed ovarian cancer patients that found that serum leptin levels were lower in advanced ovarian cancer patients in comparison to controls [44, 45] . Leptin, released from adipocytes into the systemic circulation proportionally to fat mass, acts as a master hormone controlling energy metabolism and weight balance [46] . Additionally, this adipokine controls several other critical systems, including endocrine axis, bone metabolism, as well as the immune/inflammatory response [47, 48] .
Tumour-associated IL-6 levels (such as those detectable in ascitic
Table 4 Linear regression analysis between proinflammatory cytokines and markers of energy metabolic status (BMI, leptin, ROS, GPx and SOD) Predictors
Noteworthy, the present study shows that serum leptin levels evaluated in 104 ovarian cancer patients at different stage of disease (stage I-IV) were determined both by stage of disease and serum IL-6 levels, independently of patient BMI. To date the great majority of studies on cancer patients have concluded that BMI and weight loss are the most important determinants of circulating leptin levels [49, 50] ; however, it is to be noted that in the majority of these papers the impact of weight loss and the pattern of serum leptin concentration before diagnosis or study enrolment is unknown.
Indeed, experimental and clinical studies have clarified that leptin production is not only strictly related to body weight and fat but it is also influenced by glucose utilization ability [51] [52] [53] . Acute caloric deprivation and increased energy expenditure result in a large decrease of leptin synthesis, before major changes in body weight or fat mass have actually occurred [54, 55] .
Consistently with this evidence and the findings obtained by some authors in tuberculosis patients [56] , it can be suggested that the prolonged severe inflammatory response associated to the most advanced stages of neoplastic disease is responsible for the energy metabolism impairment thus down-regulating and exhausting leptin production. Indeed, the stimulation of leptin synthesis by aerobic glucose metabolism is mediated through the production of ATP and through the effect of glucose oxidation on cellular redox status and pyruvate cycling [57] . Therefore OS, [56] .
In light of the results of the present study, we can hypothesize that in ovarian cancer patients the reduced leptin production functions as a signal of increased energy expenditure and low energy reserves during the progression of the neoplastic disease [56] . 
